Evoke Pharma Announces Closing of $7.5 Million Public Offering

SOLANA BEACH, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily ...

Related Keywords

New York ,United States ,Daniel Kontoh Boateng ,Dave Gonyer ,Syndicate Department ,Nasdaq ,Pharma Inc ,Exchange Commission ,Craig Hallum Capital Group ,Laidlaw Company United Kingdom Ltd ,Nantahala Capital Management ,Evoke Pharma Chief Executive Officer Dave ,Seriesc Warrants ,Seriesb Warrants ,Seriesb Warrant ,Seriesc Warrant ,United Kingdom ,Equity Capital Markets ,Ninth Street ,Evoke Pharma ,Private Securities Litigation Reform Act ,